Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.

about

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.

P2860

Q51350568-82D95958-DBE4-45C7-B5F2-7F4F2729151C

P2860

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.

Item

http://www.wikidata.org/entity/Q39417832

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@en

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@nl

type

Item

label

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@en

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@nl

prefLabel

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@en

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@nl

P1476

Qualitative and Quantitative R ...... ic Markers in Prostate Cancer.

@en

P2093

Aleksandra Matuszewska

http://www.w3.org/2001/XMLSchema#string

Christina Koop

http://www.w3.org/2001/XMLSchema#string

Christoph Burdelski

http://www.w3.org/2001/XMLSchema#string

Corinna Wittmer

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

Katharina Grupp

http://www.w3.org/2001/XMLSchema#string

Maria Christina Tsourlakis

http://www.w3.org/2001/XMLSchema#string

Martina Kluth

http://www.w3.org/2001/XMLSchema#string

Ronald Simon

http://www.w3.org/2001/XMLSchema#string

Sarah Minner

http://www.w3.org/2001/XMLSchema#string

P2860

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Molecular staging of prostate cancer in the year 2007.

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

P304

137-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MICROARRAYS3020137

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27600340

http://www.w3.org/2001/XMLSchema#string

P932

5003445

http://www.w3.org/2001/XMLSchema#string

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.

about

P2860

P2860

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932